OIRA Conclusion of EO 12866 Regulatory Review
| RIN: 0938-AV74 View EO 12866 Meetings | Received Date: 10/02/2025 |
| Title: Guarding U.S. Medicare Against Rising Drug Costs (GUARD) Model (CMS-5546) | |
| Agency/Subagency: HHS / CMS | Stage: Proposed Rule |
| Concluded Action: Consistent with Change | Concluded Date: 12/18/2025 |
| Legal Deadline: None | Economically Significant: Yes |
| Publication Date: | Unfunded Mandates: No |
| Major: Yes | Related To Homeland Security: No |
| Regulatory Flexibility Analysis Required: Undetermined | Small Entities Affected: |
| Federalism Implications: Yes | Affordable Care Act [Pub. L. 111-148 & 111-152]: No |
| International Impacts: No | Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No |
| Pandemic Response: No | |
An official website of the United States government




